麻烦药物:基于CRISPR-Cas查的功能基因组学方法用于药物标发现
Byung-Sun Park1, Mieun Lee1, Jaeyeol Kim1,2
1Medicinal Materials Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea.
Experimental & molecular medicine
|June 30, 2025
概括
功能性基因组学在扰动基因学中使用CRISPR屏幕来发现基因功能,并确定癌症和神经退行等疾病的治疗点,推动药物和再生医学开发.
科学领域:
- 基因组学就是基因组学.
- 功能性基因组学 功能性基因组学
- 系统生物学 系统生物学
背景情况:
- 尽管有人类基因组项目,但大量的人类基因缺乏功能特征.
- 功能性基因组学试图了解生物过程中的基因作用和相互作用.
- 波组学系统地分析基因调制的表型变化,以揭示基因功能.
研究的目的:
- 为突出基于CRISPR的扰动力学技术进步.
- 专注于单细胞分析,以获得生理学上相关的见解.
- 展示用于发现新型治疗策略的应用.
主要方法:
- 利用基于CRISPR-Cas的基因组和表观基因组编辑来调节基因功能.
- 使用CRISPR屏幕作为扰动力学研究的主要方法.
- 实施单细胞水平分析,以提高生理学相关性.
主要成果:
- 克里斯普尔屏幕识别治疗干预的目标基因.
- 扰动基因学有助于发现未注释基因的功能.
- 进步使得功能基因组学研究更准确,更具生理相关性.
结论:
- 基于CRISPR的扰动组学对于理解基因功能至关重要.
- 这种方法有助于开发针对癌症,心血管和神经退行性疾病的向治疗方法.
- 在扰动化学中单细胞分析推动了基因和细胞疗法的创新.
相关概念视频
CRISPR/Cas9 Genome Editing
343
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
343
CRISPR
53.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K


